Faculty

Nabil Adra, MD

Associate Professor of Clinical Medicine

Address

Indiana Cancer Pavilion
535 Barnhill Dr., Suite 473

Indianapolis, IN 46202-5289

Titles & Appointments

Associate Professor of Clinical Medicine
Associate Professor of Clinical Urology
Service Line Leader - Medical Oncology
Co-Medical Director - IU Health Simon Cancer Center
Program Leader - Genitourinary

Education

2010 MD American University of Beirut

2006 BS American University of Beirut
Research

Genitourinary Malignancies
Prostate Cancer
Testicular Cancer
Urothelial Cancer
Cancer Survivorship
Publications

Does pathological sub stratification of T2 bladder cancer predict outcome in a contemporary pure urothelial carcinoma cohort?
Tachibana I; Mahmoud M; Abedali ZA; Flack C; Adra N; Cheng L; Kaimaklitois HZ; Urologic oncology 2022 Feb 8

Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors.
King J; Adra N; Current oncology reports 2022 Feb 3

Phase II trial of brentuximab vedotin in relapsed/refractory germ cell tumors.
Ashkar R; Feldman DR; Adra N; Zaid MA; Funt SA; Althouse SK; Perkins SM; Snow CI; Lazzara KM; Sego LM; Quinn DI; Hanna NH; Einhorn LH; Albany C; Investigational new drugs 2021 May 24

Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS).
Grivas P; Loriot Y; Morales-Barrera R; Teo MY; Zakharia Y; Feyerabend S; Vogelzang NJ; Grande E; Adra N; Alva A; Necchi A; Rodriguez-Vida A; Gupta S; Josephs DH; Srinivas S; Wride K; Thomas D; Simmons A; Loehr A; Dusek RL; Nepert D; Chowdhury S; BMC cancer 2021 May 24

Pearls and perils in the management of germ cell tumors.
Wei CX; Einhorn LH; Adra N; Current opinion in oncology 2021 May 1

Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
Taza F; Holler AE; Fu W; Wang H; Adra N; Albany C; Ashkar R; Cheng HH; Sokolova AO; Agarwal N; Kessel A; Bryce A; Nafissi N; Barata P; Sartor AO; Bastos D; Smaletz O; Berchuck JE; Taplin ME; Aggarwal R; Sternberg CN; Vlachostergios PJ; Alva AS; Su C; Marshall CH; Antonarakis ES; JCO precision oncology 2021 Jul 22

Percentage of Teratoma in Orchiectomy and Risk of Retroperitoneal Teratoma at the Time of Postchemotherapy Retroperitoneal Lymph Node Dissection in Germ Cell Tumors.
Calaway AC; Kern SQ; Crook D; Tong Y; Masterson TA; Adra N; Einhorn LH; Foster RS; Cary C; The Journal of urology 2021 Jul 21

Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantation.
Agrawal V; Abonour R; Abu Zaid M; Althouse SK; Ashkar R; Albany C; Hanna NH; Einhorn LH; Adra N; Cancer 2021 Jul 14

Testicular Cancer: Biology to Bedside.
King J; Adra N; Einhorn LH; Cancer research 2021 Aug 11

Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection.
Cheng L; Mann SA; Lopez-Beltran A; Chovanec M; Santoni M; Wang M; Albany C; Adra N; Davidson DD; Cimadamore A; Montironi R; Zhang S; Methods in molecular biology (Clifton, N.J.) 2021

Hypermethylation and global remodelling of DNA methylation is associated with acquired cisplatin resistance in testicular germ cell tumours.
Fazal Z; Singh R; Fang F; Bikorimana E; Baldwin H; Corbet A; Tomlin M; Yerby C; Adra N; Albany C; Lee S; Freemantle SJ; Nephew KP; Christensen BC; Spinella MJ; Epigenetics 2020 Oct 30

Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors.
Nappi L; Thi M; Adra N; Hamilton RJ; Leao R; Lavoie JM; Soleimani M; Eigl BJ; Chi K; Gleave M; So A; Black PC; Bell R; Daneshmand S; Cary C; Masterson T; Einhorn L; Nichols C; Kollmannsberger C; European urology 2020 Nov 4

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer.
Sena LA; Fountain J; Isaacsson Velho P; Lim SJ; Wang H; Nizialek E; Rathi N; Nussenzveig R; Maughan BL; Velez MG; Ashkar R; Larson AC; Pritchard CC; Adra N; Bryce AH; Agarwal N; Pardoll DM; Eshleman JR; Lotan TL; Antonarakis ES; The oncologist 2020 Nov 20

A phase 1 study of combined guadecitabine and cisplatin in platinum refractory germ cell cancer.
Albany C; Fazal Z; Singh R; Bikorimana E; Adra N; Hanna NH; Einhorn LH; Perkins SM; Sandusky GE; Christensen BC; Keer H; Fang F; Nephew KP; Spinella MJ; Cancer medicine 2020 Nov 1

Management of residual disease after chemotherapy in germ cell tumors.
King J; Adra N; Einhorn LH; Current opinion in oncology 2020 May

Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
Taza F; Chovanec M; Snavely A; Hanna NH; Cary C; Masterson TA; Foster RS; Einhorn LH; Albany C; Adra N; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Mar 5

Role of Neoadjuvant Chemotherapy in Squamous Variant Histology in Urothelial Bladder Cancer: Does Presence and Percentage Matter?
Speir RW; Barboza MP; Calaway A; Masterson TA; Cary C; Koch M; Bihrle R; Cheng L; Adra N; Kaimakliotis H; Clinical genitourinary cancer 2020 Jun 19

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
Einhorn LH; Adra N; Hanna N; Nichols C; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Jul 7

Urothelial carcinoma in situ response to cisplatin-based neoadjuvant chemotherapy, or lack thereof: Impact on patient selection for organ preservation in muscle-invasive disease?
Tachibana I; Bandali E; Calaway AC; Krishnan N; Cheng L; Adra N; Kaimakliotis HZ; Urologic oncology 2020 Jul 18

Long-Term Oncologic Outcomes after Primary Retroperitoneal Lymph Node Dissection: Minimizing the Need for Adjuvant Chemotherapy.
Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C; The Journal of urology 2020 Jan 31

Risk Factors for Acute Kidney Injury During High-dose Chemotherapy and Outcomes for Patients With Relapsed Germ Cell Tumors.
Zhang KJ; Hanna NH; Althouse SK; Zaid MA; Abonour R; Albany C; Einhorn LH; Adra N; Clinical genitourinary cancer 2020 Feb 8

Reply by Authors.
Douglawi A; Calaway A; Tachibana I; Panizzutti Barboza M; Speir R; Masterson T; Adra N; Foster R; Einhorn L; Cary C; The Journal of urology 2020 Apr 24

CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.
Antonarakis ES; Isaacsson Velho P; Fu W; Wang H; Agarwal N; Sacristan Santos V; Maughan BL; Pili R; Adra N; Sternberg CN; Vlachostergios PJ; Tagawa ST; Bryce AH; McNatty AL; Reichert ZR; Dreicer R; Sartor O; Lotan TL; Hussain M; JCO precision oncology 2020 Apr 21

Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.
Agrawal V; Dinh PC Jr; Fung C; Monahan PO; Althouse SK; Norton K; Cary C; Einhorn L; Fossa SD; Adra N; Travis LB; JNCI cancer spectrum 2019 Oct 8

High-dose chemotherapy plus peripheral blood stem cell transplantation for patients with relapsed germ cell tumors and active brain metastases.
Kalra M; Adra N; Hanna N; Abonour R; Einhorn LH; Cancer 2019 Nov 19

Prolonged Survival With Reinstitution of High-Dose Chemotherapy With Peripheral Blood Stem-Cell Transplantation in a Patient With Refractory Testis Cancer.
Yan MN; Adra N; Einhorn LH; JCO oncology practice 2019 Nov 13

Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
Gawronski AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F; 2019 Feb 13

Reply to the letter to the editor 'A centralised multidisciplinary clinic approach for germ cell tumours' by Crawford.
Albany C; Adra N; Snavely A; Cary C; Masterson T; Foster R; Kesler K; Ulbright T; Cheng L; Chovanec M; Taza F; Hanna N; Einhorn L; 2018 Nov 1

Risk of Bleomycin-Related Pulmonary Toxicities and Operative Morbidity After Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Good-Risk Germ Cell Tumors.
Calaway AC; Foster RS; Adra N; Masterson TA; Albany C; Hanna NH; Einhorn LH; Cary C; 2018 Aug 29

Salvage therapy for relapsed testicular cancer.
Adra N; Einhorn LH; Oncotarget 2017 Sep 14

Phase II Trial of Pembrolizumab in Patients with Platinum Refractory Germ Cell Tumors: A Hoosier Cancer Research Network Study GU14-206.
Adra N; Einhorn LH; Althouse SK; Ammakkanavar NR; Musapatika D; Albany C; Vaughn D; Hanna NH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Oct 17

Multidisciplinary Clinic Approach Improves Overall Survival Outcomes of Patients with Metastatic Germ Cell Tumors.
Albany C; Adra N; Snavely AC; Cary C; Masterson TA; Foster RS; Kesler K; Ulbright TM; Cheng L; Chovanec M; Taza F; Ku K; Brames MJ; Hanna NH; Einhorn LH; Annals of oncology : official journal of the European Society for Medical Oncology 2017 Nov 10

Testicular cancer update.
Adra N; Einhorn LH; Clinical advances in hematology & oncology : H&O 2017 May

TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer.
Adra N; Cheng L; Hanna NH; Durm G; Clinical genitourinary cancer 2017 Feb 1

High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience.
Adra N; Abonour R; Althouse SK; Albany C; Hanna NH; Einhorn LH; Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2016 Nov 21

Chemotherapy-Related Chronic Myelogenous Leukemia: A Case Series of Patients With Germ Cell Tumor.
Adra N; Sayar H; Einhorn LH; 2016 Mar

Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.
Adra N; Althouse SK; Liu H; Brames MJ; Hanna NH; Einhorn LH; Albany C; 2016 Feb 9

Phase II study of fosaprepitant?+?5HT3 receptor antagonist?+?dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Adra N; Albany C; Brames MJ; Case-Eads S; Johnson CS; Liu Z; Fausel CA; Breen T; Hanna NH; Hauke RJ; Picus J; Einhorn LH; 2016 Feb 2

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab.
Adra N; Cheng L; Pili R; Clinical genitourinary cancer 2016 Dec 29

A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C; 2016 Aug 8
Board Certifications

American Board of Internal Medicine - Internal Medicine

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor